Skip to content

Prosight Management, LP

Follow

13F filer, CIK 1617201, DALLAS, TX

Prosight Management, LP reported $515,482,740 across 32 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 70.63% of the portfolio.

Accepted , ingested 13F-HR 0001420506-26-002713

Period
2026-09-30
Reported value
$515M
Holdings
32
Top 10 weight
70.63%
New
9
Sold out
13

Part of the filer group Prosight Management, LP

  • Prosight Fund, LP
  • Prosight Partners, LLC
  • Prosight Plus Fund, LP
  • W. Lawrence Hawkins
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ABVXadded+269,400$26.7M
PRVAnew+1,049,752$20.7M
STTKadded+1,690,217$11.5M
DNLInew+550,700$11.4M
PRAXnew+36,400$10.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BSXreduced-720,273-$31.4M
VEEVexited-106,200-$18.8M
INSMreduced-137,521-$15.7M
ALNYreduced-61,080-$15.1M
JANXreduced-861,281-$14.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001420506-26-002713, largest first. % of portfolio is the value over $515,482,740, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LKFTLAKEFRONT BIOTHERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,025,000 shares; 2025Q1: 1,314,898 shares; 2025Q2: 1,773,649 shares; 2025Q3: 1,150,000 shares; 2025Q4: 1,074,112 shares; 2026Q1: 1,550,000 shares; 2026Q2: 2,043,344 shares; 2026Q3: 1,998,400 shares 1,998,400$59.3M11.49%-44,944Timeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,638,935 shares; 2025Q1: 6,638,935 shares; 2025Q2: 6,638,935 shares; 2025Q3: 5,451,195 shares; 2025Q4: 2,381,502 shares; 2026Q1: 5,004,439 shares; 2026Q2: 5,957,877 shares; 2026Q3: 7,648,094 shares 7,648,094$52.2M10.12%+1,690,217Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 329,768 shares; 2025Q1: 689,901 shares; 2025Q2: 853,904 shares; 2025Q3: 865,350 shares; 2025Q4: 2,392,523 shares; 2026Q1: 3,550,000 shares; 2026Q2: 3,804,481 shares; 2026Q3: 2,943,200 shares 2,943,200$50.9M9.87%-861,2812026-11-10, 13G/A: 3,150,450 shares, 5.15% of the class, 13G/A filed 2026-11-13 Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 554,633 shares; 2026Q1: 735,000 shares; 2026Q2: 810,000 shares; 2026Q3: 785,000 shares 785,000$47.5M9.22%-25,000Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,000 shares; 2026Q1: 105,000 shares; 2026Q2: 107,394 shares; 2026Q3: 376,794 shares 376,794$37.3M7.24%+269,400Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 375,609 shares; 2026Q3: 238,088 shares 238,088$27.2M5.27%-137,521Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 76,100 shares; 2025Q4: 210,000 shares; 2026Q1: 795,547 shares; 2026Q2: 1,270,273 shares; 2026Q3: 550,000 shares 550,000$24M4.66%-720,273Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 10,000 shares; 2026Q2: 165,500 shares; 2026Q3: 200,980 shares 200,980$22.8M4.43%+35,480Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 513,632 shares; 2026Q2: 394,389 shares; 2026Q3: 550,000 shares 550,000$22.3M4.32%+155,611Timeline
PRVAPRIVIA HEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,049,752 shares 1,049,752$20.7M4.01%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 449,795 shares; 2026Q3: 800,000 shares 800,000$20.1M3.9%+350,205Timeline
ZYMEZYMEWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 820,000 shares; 2025Q1: 957,229 shares; 2025Q2: 1,309,904 shares; 2025Q3: 749,611 shares; 2025Q4: 530,393 shares; 2026Q1: 539,049 shares; 2026Q2: 674,434 shares; 2026Q3: 721,100 shares 721,100$19.1M3.71%+46,666Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 620,000 shares; 2025Q1: 609,252 shares; 2025Q2: 1,079,673 shares; 2025Q3: 1,003,400 shares; 2025Q4: 665,000 shares; 2026Q1: 770,000 shares; 2026Q2: 1,200,000 shares; 2026Q3: 812,582 shares 812,582$15.3M2.96%-387,418Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,325,000 shares; 2025Q1: 2,078,315 shares; 2025Q2: 3,181,184 shares; 2025Q3: 2,758,516 shares; 2025Q4: 2,529,600 shares; 2026Q1: 3,356,700 shares; 2026Q2: 2,021,964 shares; 2026Q3: 1,275,000 shares 1,275,000$13.7M2.65%-746,964Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 550,700 shares 550,700$11.4M2.21%newTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 36,400 shares 36,400$10.6M2.06%newTimeline
HQYHEALTHEQUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 115,796 shares 115,796$10.2M1.99%newTimeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 995,000 shares; 2025Q1: 610,000 shares; 2025Q2: 472,687 shares; 2025Q3: 264,500 shares; 2025Q4: 30,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 150,000 shares 150,000$9.87M1.91%newTimeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,109 shares; 2026Q1: 76,000 shares; 2026Q2: 98,080 shares; 2026Q3: 37,000 shares 37,000$9.13M1.77%-61,080Timeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 22,000 shares 22,000$8.39M1.63%newTimeline
ENOVENOVIS CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 267,432 shares 267,432$4.89M0.95%newTimeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 63,754 shares; 2025Q1: 186,570 shares; 2025Q2: 159,692 shares; 2025Q3: 267,959 shares; 2025Q4: 816,909 shares; 2026Q1: 2,154,381 shares; 2026Q2: 978,992 shares; 2026Q3: 1,325,570 shares 1,325,570$3.61M0.7%+346,578Timeline
QTRXQUANTERIX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 825,000 shares 825,000$3.06M0.59%newTimeline
GENBGENERATE BIOMEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 144,756 shares 144,756$2.17M0.42%newTimeline
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 515,754 shares; 2026Q2: 474,638 shares; 2026Q3: 350,877 shares 350,877$1.87M0.36%-123,761Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 334,263 shares; 2025Q2: 837,400 shares; 2025Q3: 20,487 shares; 2025Q4: 1,555,744 shares; 2026Q1: 1,667,600 shares; 2026Q2: 1,370,233 shares; 2026Q3: 1,604,466 shares 1,604,466$1.73M0.34%+234,233Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,088,706 shares; 2025Q1: 1,480,000 shares; 2025Q2: 1,580,588 shares; 2025Q3: 1,267,965 shares; 2025Q4: 743,942 shares; 2026Q1: 683,856 shares; 2026Q2: 700,000 shares; 2026Q3: 595,024 shares 595,024$1.56M0.3%-104,976Timeline
RNTXREIN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 404,979 shares; 2025Q1: 430,000 shares; 2025Q2: 427,919 shares; 2025Q3: 567,898 shares; 2025Q4: 442,600 shares; 2026Q1: 411,600 shares; 2026Q2: 1,100,000 shares; 2026Q3: 1,660,197 shares 1,660,197$1.33M0.26%+560,197Timeline
COYACOYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 420,360 shares; 2026Q2: 170,000 shares; 2026Q3: 229,600 shares 229,600$1.15M0.22%+59,600Timeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 270,000 shares; 2025Q1: 575,136 shares; 2025Q2: 579,893 shares; 2025Q3: 343,400 shares; 2025Q4: 683,872 shares; 2026Q1: 697,108 shares; 2026Q2: 650,000 shares; 2026Q3: 168,383 shares 168,383$1.15M0.22%-481,617Timeline
IMRXIMMUNEERING CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 123,409 shares; 2026Q2: 36,861 shares; 2026Q3: 150,000 shares 150,000$614K0.12%+113,139Timeline
ADCTADC THERAPEUTICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,515,000 shares; 2025Q1: 9,543,004 shares; 2025Q2: 10,467,771 shares; 2025Q3: 7,472,303 shares; 2025Q4: 8,477,338 shares; 2026Q1: 8,300,000 shares; 2026Q2: 7,824,749 shares; 2026Q3: 399,900 shares 399,900$488K0.09%-7,424,849Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VEEVVEEVA SYS INC106,200$18.8Mshares
CRNXCRINETICS PHARMACEUTICALS IN374,666$14Mshares
ICUIICU MED INC51,000$7.48Mshares
ISRGINTUITIVE SURGICAL INC17,000$6.76Mshares
PRCTPROCEPT BIOROBOTICS CORP268,269$6.06Mshares
WGSGENEDX HOLDINGS CORP85,500$5.87Mshares
OPCHOPTION CARE HEALTH INC270,716$5.68Mshares
EBSEMERGENT BIOSOLUTIONS INC459,952$3.85Mshares
PFEPFIZER INC135,366$3.26Mshares
KIDSORTHOPEDIATRICS CORP157,500$3.01Mshares
TECXTECTONIC THERAPEUTIC INC39,731$1.37Mshares
MGTXMEIRAGTX HLDGS PLC90,000$1.22Mshares
EFOREVERFORTH INC67,500$1.21Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-002713 base2026-11-13